Theranos, the blood testing startup based in Palo Alto, Calif., ran a hematology test on 81 patients in a six-month period despite erratic results from quality-control checks, according to The Wall ...

Walgreens has reached a tentative settlement with consumers who took faulty Theranos blood tests, according to a court document filed Monday. The proposed settlement agreement will be filed in about ...

Palo Alto, Calif.-based Theranos is standing by 99 percent of its blood test results. Theranos retracted two years of tests conducted on its proprietary “Edison” device last month and it is now saying ...

There was a time when Walgreens championed Theranos' blood tests and offered them at "wellness centers" in its stores. That was before it came to light that Theranos' tests were faulty, leading to a ...

Elizabeth Holmes dropped out of Stanford at 19 to start the blood-testing startup Theranos. Theranos' value grew to $9 billion until flaws in the technology were exposed and Holmes was charged with ...

Lawyers for Theranos founder Elizabeth Holmes asked a federal judge to place new restrictions on the scope of evidence that prosecutors can present at her coming criminal-fraud trial, arguing her ...

The month after Marrinucci co-founded Truvian, The Wall Street Journal published an exposé accusing Theranos—Truvian's now infamous, defunct competitor—of misrepresenting the accuracy and reliability ...

Share on Facebook (opens in a new window) Share on X (opens in a new window) Share on Reddit (opens in a new window) Share on Hacker News (opens in a new window) Share on Flipboard (opens in a new ...

At Theranos founder Elizabeth Holmes’ trial on Tuesday, an Arizona woman testified that she could have terminated her pregnancy because of a faulty blood test she received from the Silicon Valley ...

Palo Alto-based novel blood test company Theranos was granted a waiver from the FDA allowing the company to offer its first FDA-cleared blood test, its herpes simplex 1 virus IgG (HSV IgG) test, ...

Theranos, the 12-year-old Palo Alto-based company working on a smaller, cheaper, alternative to common lab blood tests, has received its first voluntary FDA 510(k) clearance, for its herpes simplex 1 ...